MANHASSET, NY – The Feinstein Institute for Medical Research and its medical journal, Molecular Medicine, announced today that the fifth Anthony Cerami Award in Translational Medicine will be conferred to Lawrence Steinman, MD, professor of neurology and neurological sciences, pediatrics and genetics at Stanford University. The award is in recognition of his research in neurology and specifically multiple sclerosis (MS).
The Cerami award, which includes a $20,000 prize, is awarded by the editors of Molecular Medicine, a peer-reviewed, open-access journal published by the Feinstein Institute. A monograph authored by Dr. Steinman, entitled “A Journey in Science: The Privilege of Exploring the Brain and the Immune System,” will be published on the Molecular Medicine website, www.molmed.org, Thursday, June 2.
In his monograph, Dr. Steinman writes that “Translational research requires a diverse team, and one should realize that it is not possible to have real expertise across the wide swath of fields necessary to go from the bench to the bedside. Therefore, teamwork and cooperation are essential for translational medicine.”
“I am honored to receive the Anthony Cerami Award in Translational Medicine,” said Dr. Steinman. “In telling the story of this scientific journey, I wanted to honor my parents, family and colleagues who helped in so many ways to make this possible. I hope that all who read the monograph find it informative, with some interesting lessons for young scientists embarking on a career in translational medicine.”
The Feinstein Institute is committed to celebrating the stewardship of the scientific process and imparting that perspective to young scientists. The Feinstein Institute also recognizes that the story behind making a discovery in medicine and healthcare is cherished and should be documented. The goal of the Cerami Award and its associated monographs is to document such innovations and discoveries, so that they can endure and inspire future generations of investigators. The Anthony Cerami Award in Translational Medicine was made possible by the generosity of Dr. Cerami and Ann Dunne Foundation for World Health. Dr. Cerami’s breakthrough translational work includes the identification of anti-TNF’s potential to treat a number of inflammatory diseases, including rheumatoid arthritis, and the development of the HbA1c Diagnostic Test, currently the gold standard for the diagnosis and control of diabetes. He is currently working on a potential treatment of diabetes as CEO of Araim Pharmaceuticals.
About Molecular Medicine
Molecular Medicine is an open access, international, peer-reviewed biomedical journal published by the Feinstein Institute Press. Molecular Medicine strives to understand normal body functioning and disease pathogenesis at the molecular level, which may allow researchers and physician-scientists to use that knowledge in the design of specific molecular tools for disease diagnosis, treatment, prognosis, and prevention. To learn more, visit www.molmed.org.
About The Feinstein Institute for Medical Research
The Feinstein Institute for Medical Research, the research arm of Northwell Health, is home to international scientific leaders. We rank in the top 6th percentile of all National Institutes of Health grants awarded to research institutes. We’re making breakthroughs in many areas, including genetics, oncology, brain research, mental health, autoimmunity and immunology, and bioelectronic medicine – a new field of science that has the potential to revolutionize medicine. For more information about how we empower imagination and pioneer discovery, visit FeinsteinInstitute.org.